TIM4 regulates the anti-islet Th2 alloimmune response
Supporting Files
-
Mar 07 2014
-
Details
-
Alternative Title:Cell Transplant
-
Personal Author:Vergani, Andrea ; Gatti, Francesca ; Lee, Kang M. ; D’Addio, Francesca ; Tezza, Sara ; Chin, Melissa ; Bassi, Roberto ; Tian, Ze ; Wu, Erxi ; Maffi, Paola ; Nasr, Moufida Ben ; Kim, James I. ; Secchi, Antonio ; Markmann, James F. ; Rothstein, David M. ; Turka, Laurence A. ; Sayegh, Mohamed H. ; Fiorina, Paolo
-
Description:The role of the novel costimulatory molecule TIM4 in anti-islet response is unknown. We explored TIM4 expression and targeting in Th1 (BALB/c islets into C57BL/6 mice) and Th2 (BALB/c islets into Tbet(-/-) C57BL/6 mice) models of anti-islet alloimmune response and in a model of anti-islet autoimmune response (diabetes onset in NOD mice). The targeting of TIM4, using the monoclonal antibody RMT4-53, promotes islet graft survival in a Th1 model, with 30% of the graft surviving in the long term; islet graft protection appears to be mediated by a Th1 to Th2 skewing of the immune response. Differently, in the Th2 model, TIM4 targeting precipitates graft rejection by further enhancing the Th2 response. The effect of anti-TIM4 treatment in preventing autoimmune diabetes was marginal with only minor Th1 to Th2 skewing. B-Cell depletion abolished the effect of TIM4 targeting. TIM4 is expressed on human B-cells and is upregulated in diabetic and islet-transplanted patients. Our data suggest a model in which TIM4 targeting promotes Th2 response over Th1 via B-cells. The targeting of TIM4 could become a component of an immunoregulatory protocol in clinical islet transplantation, aiming at redirecting the immune system toward a Th2 response.
-
Subjects:
-
Source:Cell Transplant. 24(8):1599-1614.
-
Pubmed ID:24612609
-
Pubmed Central ID:PMC4280358
-
Document Type:
-
Funding:
-
Volume:24
-
Issue:8
-
Collection(s):
-
Main Document Checksum:urn:sha256:c3e0293bfbb725b78ea745e5ae84b03a2304d0a8854c2653a0ad931127a3f42a
-
Download URL:
-
File Type:
Supporting Files
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access